METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY

This application describes methods of treating alpha-1 antitrypsin deficiency (AATD) comprising administering Compound I, a deuterated derivative thereof, and/or a pharmaceutically acceptable salt thereof. The application also describes pharmaceutical compositions comprising Compound I, a deuterated...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HARE, BRIAN J, MARIGOWDA, GAUTHAM, TIAN, BOSHENG, PANORCHAN, PORNTULA, ZHANG, WEIYAN, BOZIC, CARMEN, CIRINCIONE, BRENDA, INGENITO, EDWARD, KUMAR, SANJEEV, RHEE, DAVID, STILES, DAVID KENT, PETERSON, MARK CHRISTOPHER
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This application describes methods of treating alpha-1 antitrypsin deficiency (AATD) comprising administering Compound I, a deuterated derivative thereof, and/or a pharmaceutically acceptable salt thereof. The application also describes pharmaceutical compositions comprising Compound I, a deuterated derivative thereof, and/or a pharmaceutically acceptable salt thereof. Cette invention concerne des procédés de traitement d'une déficience en Alpha-1 antitrypsine (AATD) comprenant l'administration du composé I, d'un dérivé deutéré de celui-ci, et/ou d'un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également des compositions pharmaceutiques comprenant le composé I, un dérivé deutéré de celui-ci, et/ou un sel pharmaceutiquement acceptable de celui-ci.